These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34452217)

  • 1. In Vitro-In Silico Tools for Streamlined Development of Acalabrutinib Amorphous Solid Dispersion Tablets.
    Mudie DM; Stewart AM; Rosales JA; Adam MS; Morgen MM; Vodak DT
    Pharmaceutics; 2021 Aug; 13(8):. PubMed ID: 34452217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amorphous Solid Dispersion Tablets Overcome Acalabrutinib pH Effect in Dogs.
    Mudie DM; Stewart AM; Rosales JA; Biswas N; Adam MS; Smith A; Craig CD; Morgen MM; Vodak DT
    Pharmaceutics; 2021 Apr; 13(4):. PubMed ID: 33921109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel High-Drug-Loaded Amorphous Dispersion Tablets of Posaconazole;
    Mudie DM; Stewart AM; Biswas N; Brodeur TJ; Shepard KB; Smith A; Morgen MM; Baumann JM; Vodak DT
    Mol Pharm; 2020 Dec; 17(12):4463-4472. PubMed ID: 32835489
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Jermain SV; Lowinger MB; Ellenberger DJ; Miller DA; Su Y; Williams RO
    Mol Pharm; 2020 Aug; 17(8):2789-2808. PubMed ID: 32520562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel architecture for achieving high drug loading in amorphous spray dried dispersion tablets.
    Mudie DM; Buchanan S; Stewart AM; Smith A; Shepard KB; Biswas N; Marshall D; Ekdahl A; Pluntze A; Craig CD; Morgen MM; Baumann JM; Vodak DT
    Int J Pharm X; 2020 Dec; 2():100042. PubMed ID: 32154509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An enteric polymer mitigates the effects of gastric pH on oral absorption of poorly soluble weak acid drugs from supersaturable formulations: A case study with dantrolene.
    Kataoka M; Nakanishi R; Umesaki M; Kobayashi M; Minami K; Higashino H; Yamaguchi S; Yamashita S
    Eur J Pharm Biopharm; 2020 Oct; 155():29-36. PubMed ID: 32771692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface Characterization as a Tool for Identifying the Factors Affecting the Dissolution Rate of Amorphous Solid Dispersion Tablets.
    Yu D; Fiddler F; Ibrahim A; Sanedrin R; Tremblay H; Hoag SW
    AAPS PharmSciTech; 2022 Oct; 23(8):282. PubMed ID: 36253562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient development of sorafenib tablets with improved oral bioavailability enabled by coprecipitated amorphous solid dispersion.
    Song S; Wang C; Wang S; Siegel RA; Sun CC
    Int J Pharm; 2021 Dec; 610():121216. PubMed ID: 34688849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of Films to Anticipate Effect of Drug Load and Polymer on Dissolution Performance from Tablets of Amorphous Itraconazole Spray-Dried Dispersions.
    Honick M; Sarpal K; Alayoubi A; Zidan A; Hoag SW; Hollenbeck RG; Munson EJ; Polli JE
    AAPS PharmSciTech; 2019 Nov; 20(8):331. PubMed ID: 31677012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Surfactants on Itraconazole-Hydroxypropyl Methylcellulose Acetate Succinate Solid Dispersion Prepared by Hot Melt Extrusion III: Tableting of Extrudates and Drug Release From Tablets.
    Solanki NG; Kathawala M; Serajuddin ATM
    J Pharm Sci; 2019 Dec; 108(12):3859-3869. PubMed ID: 31542437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of HPMCAS on the Dissolution Performance of Polyvinyl Alcohol Celecoxib Amorphous Solid Dispersions.
    Monschke M; Wagner KG
    Pharmaceutics; 2020 Jun; 12(6):. PubMed ID: 32545270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of polymer type, ASD loading and polymer-drug ratio on ASD tablet disintegration and drug release.
    Zhang W; Noland R; Chin S; Petkovic M; Zuniga R; Santarra B; Conklin B; Hou HH; Nagapudi K; Gruenhagen JA; Yehl P; Chen T
    Int J Pharm; 2021 Jan; 592():120087. PubMed ID: 33189812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Surfactants on Itraconazole-HPMCAS Solid Dispersion Prepared by Hot-Melt Extrusion I: Miscibility and Drug Release.
    Solanki NG; Lam K; Tahsin M; Gumaste SG; Shah AV; Serajuddin ATM
    J Pharm Sci; 2019 Apr; 108(4):1453-1465. PubMed ID: 30395834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced bioavailability of a poorly soluble VR1 antagonist using an amorphous solid dispersion approach: a case study.
    Kennedy M; Hu J; Gao P; Li L; Ali-Reynolds A; Chal B; Gupta V; Ma C; Mahajan N; Akrami A; Surapaneni S
    Mol Pharm; 2008; 5(6):981-93. PubMed ID: 19434920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amorphous solid dispersion of nisoldipine by solvent evaporation technique: preparation, characterization, in vitro, in vivo evaluation, and scale up feasibility study.
    Chavan RB; Lodagekar A; Yadav B; Shastri NR
    Drug Deliv Transl Res; 2020 Aug; 10(4):903-918. PubMed ID: 32378174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relevance of Liquid-Liquid Phase Separation of Supersaturated Solution in Oral Absorption of Albendazole from Amorphous Solid Dispersions.
    Suzuki K; Kawakami K; Fukiage M; Oikawa M; Nishida Y; Matsuda M; Fujita T
    Pharmaceutics; 2021 Feb; 13(2):. PubMed ID: 33562770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downstream processing of spray-dried ASD with hypromellose acetate succinate - Roller compaction and subsequent compression into high ASD load tablets.
    Sauer A; Warashina S; Mishra SM; Lesser I; Kirchhöfer K
    Int J Pharm X; 2021 Dec; 3():100099. PubMed ID: 34765966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Drug-Rich Colloids of Itraconazole and HPMCAS on Membrane Flux in Vitro and Oral Bioavailability in Rats.
    Stewart AM; Grass ME; Brodeur TJ; Goodwin AK; Morgen MM; Friesen DT; Vodak DT
    Mol Pharm; 2017 Jul; 14(7):2437-2449. PubMed ID: 28591516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of supersaturation on the oral bioavailability of paclitaxel/polymer amorphous solid dispersion.
    Miao L; Liang Y; Pan W; Gou J; Yin T; Zhang Y; He H; Tang X
    Drug Deliv Transl Res; 2019 Feb; 9(1):344-356. PubMed ID: 30187352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Designing an ADME liquid formulation with matching exposures to an amorphous dosage form.
    Xi H; Yang Z; Tatavarti A; Xu W; Fuerst J; Ormes J
    Int J Pharm; 2019 Jan; 554():48-53. PubMed ID: 30236644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.